Sheaff Brock Investment Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $1.59M | Sell |
62,940
-3,699
| -6% | -$96.8K | 0.15% | 122 |
|
|
2024
Q4 | $1.77M | Sell |
66,639
-7,815
| -10% | -$212K | 0.15% | 118 |
|
|
2024
Q3 | $2.15M | Buy |
74,454
+87
| +0.1% | +$2.54K | 0.19% | 105 |
|
|
2024
Q2 | $2.08M | Sell |
74,367
-3,571
| -5% | -$98.3K | 0.19% | 102 |
|
|
2024
Q1 | $2.16M | Buy |
77,938
+1,188
| +2% | +$33K | 0.14% | 114 |
|
|
2023
Q4 | $2.21M | Sell |
76,750
-3,837
| -5% | -$116K | 0.17% | 97 |
|
|
2023
Q3 | $2.67M | Buy |
80,587
+1,390
| +2% | +$49.2K | 0.24% | 80 |
|
|
2023
Q2 | $2.9M | Sell |
79,197
-2,480
| -3% | -$96.5K | 0.24% | 80 |
|
|
2023
Q1 | $3.33M | Sell |
81,677
-1,128
| -1% | -$48.7K | 0.31% | 71 |
|
|
2022
Q4 | $4.24M | Buy |
82,805
+1,187
| +1% | +$56.9K | 0.42% | 57 |
|
|
2022
Q3 | $3.57M | Buy |
81,618
+834
| +1% | +$40.5K | 0.38% | 59 |
|
|
2022
Q2 | $4.24M | Sell |
80,784
-510
| -0.6% | -$26K | 0.35% | 58 |
|
|
2022
Q1 | $4.21M | Sell |
81,294
-622
| -0.8% | -$32.3K | 0.29% | 63 |
|
|
2021
Q4 | $4.84M | Buy |
81,916
+4,664
| +6% | +$231K | 0.32% | 57 |
|
|
2021
Q3 | $3.32M | Sell |
77,252
-14,044
| -15% | -$622K | 0.24% | 75 |
|
|
2021
Q2 | $3.58M | Sell |
91,296
-118
| -0.1% | -$4.59K | 0.26% | 71 |
|
|
2021
Q1 | $3.31M | Sell |
91,414
-3,216
| -3% | -$114K | 0.26% | 72 |
|
|
2020
Q4 | $3.48M | Buy |
94,630
+10,319
| +12% | +$379K | 0.29% | 67 |
|
|
2020
Q3 | $2.94M | Buy |
84,311
+7,589
| +10% | +$266K | 0.27% | 71 |
|
|
2020
Q2 | $2.38M | Sell |
76,722
-365
| -0.5% | -$12.4K | 0.24% | 74 |
|
|
2020
Q1 | $2.39M | Sell |
77,087
-12,166
| -14% | -$415K | 0.32% | 63 |
|
|
2019
Q4 | $3.32M | Buy |
89,253
+1,087
| +1% | +$38.7K | 0.32% | 61 |
|
|
2019
Q3 | $3.01M | Sell |
88,166
-783
| -0.9% | -$28.5K | 0.33% | 57 |
|
|
2019
Q2 | $3.66M | Sell |
88,949
-2,065
| -2% | -$82K | 0.39% | 52 |
|
|
2019
Q1 | $3.67M | Buy |
91,014
+9,317
| +11% | +$373K | 0.45% | 54 |
|
|
2018
Q4 | $3.38M | Sell |
81,697
-173,395
| -68% | -$7.2M | 0.53% | 53 |
|
|
2018
Q3 | $10.7M | Sell |
255,092
-5,771
| -2% | -$222K | 1.01% | 12 |
|
|
2018
Q2 | $8.98M | Sell |
260,863
-7,632
| -3% | -$261K | 0.88% | 16 |
|
|
2018
Q1 | $9.04M | Sell |
268,495
-328
| -0.1% | -$11.3K | 0.94% | 16 |
|
|
2017
Q4 | $9.24M | Sell |
268,823
-2,852
| -1% | -$97.2K | 1.2% | 16 |
|
|
2017
Q3 | $9.2M | Buy |
271,675
+1,058
| +0.4% | +$34K | 1.21% | 14 |
|
|
2017
Q2 | $8.62M | Buy |
270,617
+6,318
| +2% | +$199K | 1.14% | 13 |
|
|
2017
Q1 | $8.58M | Sell |
264,299
-23,128
| -8% | -$729K | 1.12% | 13 |
|
|
2016
Q4 | $8.86M | Buy |
287,427
+139,986
| +95% | +$4.27M | 1.12% | 10 |
|
|
2016
Q3 | $4.74M | Buy |
147,441
+12,023
| +9% | +$402K | 0.63% | 36 |
|
|
2016
Q2 | $4.52M | Sell |
135,418
-23,076
| -15% | -$736K | 0.57% | 42 |
|
|
2016
Q1 | $4.46M | Sell |
158,494
-12,647
| -7% | -$361K | 0.55% | 40 |
|
|
2015
Q4 | $5.24M | Buy |
+171,141
| New | +$5.38M | 0.59% | 39 |
|
Other funds holding PFE
TIM
Sheaff Brock Investment Advisors's PFE Position: Q1 2025 in Review
Sheaff Brock Investment Advisors reduced its Pfizer (PFE) stake by 5.6% in Q1 2025, selling an estimated $96.8K and leaving 62,940 shares worth $1.59M. The position accounts for 0.15% of the portfolio, ranked #122.
Sheaff Brock Investment Advisors first reported a position in PFE in Q4 2015 and has held it in 38 quarters since. The position peaked at $10.7M in Q3 2018. 2,930 funds tracked by Wall St. Rank hold PFE as of Q1 2025.
- Sheaff Brock Investment Advisors held 62,940 shares of Pfizer worth $1.59M as of Q1 2025.
- Sheaff Brock Investment Advisors sold 3,699 Pfizer shares in Q1 2025, an estimated $96.8K.
- Pfizer made up 0.15% of Sheaff Brock Investment Advisors's portfolio in Q1 2025, its #122 holding.
- Sheaff Brock Investment Advisors first reported a position in Pfizer in Q4 2015 and has held it in 38 quarters since.
- Sheaff Brock Investment Advisors's Pfizer position peaked at $10.7M in Q3 2018.
- 2,930 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.
Based on Sheaff Brock Investment Advisors's 13F filing for Q1 2025, filed 7 May 2025.